site sponsored by
Tag Archive | "parkinson"
Tags: biotech, entereg, parkinson, premier-john, private-sector, program-since, service-division, though-the-drug, vernalis, vipadenant, will-refocus
Vernalis Parkinson’s drug sinks on tox issues
Posted on 16 July 2010
Posted in Top NewsComments (0)
Tags: find-signature, identification, methods-before, million-upfront, parkinson, president, remaining, underwriters
In pursuit of CNS pipeline, Biovail buys compounds from Cortex
Posted on 26 March 2010
Posted in Top NewsComments (0)
&h=57&w=100&zc=1&q=80" alt="Mirapexin – Managing movement and more" class="th" />
Tags: adpharm, adpharm gallery, advertising, disease, europe, largest, managing, mirapexin, parkinson, pramipexole, Print, single-page, the-largest
Mirapexin – Managing movement and more
Posted on 22 March 2010
Posted in Pharma AdsComments (0)
&h=57&w=100&zc=1&q=80" alt="Azilect – simply effective" class="th" />
Tags: adpharm, adpharm gallery, advertising, dual-benefits, europe, irish, largest, parkinson, pharmaceuticals, Print, rasagiline, simply-effective, single-page, the-largest
Azilect – simply effective
Posted on 12 March 2010
Posted in Pharma AdsComments (0)
Tags: broadens-the-indication, ertaczo-cream, fda, firm, following-its, ingelheim, parkinson
Boehringer Ingelheim broadens YouTube, Twitter efforts
Posted on 26 August 2009
Posted in Pharma AdsComments (0)
Tags: allow-embedding, been-the-most, channel, channel-which, channels, daddy, maintenance, new and social media, parkinson, video
New Offerings by Pharma on YouTube
Posted on 25 August 2009
Posted in RegulatoryComments (0)
Tags: action-method, ehealth, epharma, hectic-schedule, his-recent, london, parkinson, patient, patient-manager, pharma deals, physicians 2.0, year
Are Physician’s Doing Enough?
Posted on 20 April 2009
Posted in Web MarketingComments (0)
Ask Our Experts
Heather R. Powell
Regulatory
Dawn Obermoeller
Social Media
Jonathan Richman
Non-Personal Promotion
Optimize RX
Internet Marketing & Analytics
Share Your Knowledge
We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.
- Popular
- Latest
- Comments
- Tags
- Subscribe
- Design: Flash-banner-eyebrow nightmare
- Even After Patent Cliff, Pfizer Is Undervalued
- Sanofi Board Said to Support Genzyme Bid of Up to $18.7 Billion
- FTC: âTide May Be Turningâ On Pay-To-Delay Deals
- Celgene Beats and Raises Guidance
- Who is Killing the Pharmaceutical Sales Position?
- Snafi – HCP print ad in the UAE
- Hospira plans big study for new Epogen biosimilar
- New from OSI / Astellas
- Athersys buoyed by upbeat PhI stem cell data
- Optimize RX: yep - recvd - thanks - how much daily u.v.'s r u g...
- JMB: This is another bashing article from an author who...
- Martin: It's just silly of you to obsess over the possibil...
- Gregg Feris: Jon, Thanks for the in depth reply. I like the ...
- Doc: Why should Exxon have to pay this fine for somethi...
2009
adpharm
adpharm gallery
advertising
alpha
biotech
bnet
branded
business
development
drug
DTC
english
europe
fda
fierce-biotech
fierce pharma
gallery
hcp
health
industry
internet
largest
marketing
motley-fool
News
north
north america
north_america
online
online-pharmaceutical
pharma
Print
print_ad
Regulatory
sales
seeking-alpha
single-page
Social Media
technology
the-gallery
the-largest
time
usa
wsj
Stay up to date
- Subscribe to the RSS Feed
